bendamustine hydrochloride has been researched along with Agammaglobulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, S; Koyama, D; Misawa, K; Sukegawa, M; Suzuki, M; Teshirogi, M; Tsunoda, S | 1 |
| Gafter-Gvili, A; Polliack, A | 1 |
1 review(s) available for bendamustine hydrochloride and Agammaglobulinemia
| Article | Year |
|---|---|
Bendamustine associated immune suppression and infections during therapy of hematological malignancies.
Topics: Agammaglobulinemia; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Hematologic Neoplasms; Humans; Immune System; Immunosuppressive Agents; Infections; Lymphopenia | 2016 |
1 other study(ies) available for bendamustine hydrochloride and Agammaglobulinemia
| Article | Year |
|---|---|
Serum IgG and lymphocyte counts are useful for the early detection of infection in patients receiving bendamustine-rituximab therapy.
Topics: Agammaglobulinemia; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Immunoglobulin G; Lymphocyte Count; Lymphoma, Non-Hodgkin; Lymphopenia; Retrospective Studies; Rituximab | 2022 |